Navigation Links
Huifeng Bio-Pharmaceutical Technology, Inc. to Attend 2011 CPhI Frankfurt
Date:10/10/2011

XI'AN, China, Oct. 10, 2011 /PRNewswire-Asia-FirstCall/ -- Huifeng Bio-Pharmaceutical Technology, Inc. (OTC Pink: HFGB) ("Huifeng" or the "Company"), a Xi'an, China-based developer and producer of botanical extracts and other raw materials used in pharmaceuticals and food additives, today announced its subsidiary Shaanxi Huifeng Pharmaceutical Ltd. will attend the CPhI Worldwide Frankfurt 2011 in Germany.

The three-day event will take place from October 25-27 at the Messe Frankfurt exhibition grounds, located at Ludwig-Ernhard-Anlage 1, Frankfurt am Main, Germany, 60327.  Huifeng's booth number will be 31C23 and located in Hall 3.1. Shaanxi Huifeng Pharmaceutical Ltd. has obtained Diosmin COS certificate in May, 2011. In this event, Huifeng plans to showcase its Diosmin and Rutin series products including Rutin NF11, Rutin DAB10, EP7, Troxerutin EP7, Quercetin, Rhamnose.

"We are really looking forward to attending the 2011 CPhI Worldwide Conference," said Huifeng's Founder, Executive Chairman and CEO, Jing'an Wang. "It will be a great opportunity to meet with customers and other businesses from around the globe, and to talk with them about the industry in general and our products' competitive advantages in particular. Attending CPhI's recent exhibition in Shanghai, China was an excellent learning experience for us, and we believe that CPhI's upcoming event in Frankfurt, Germany will provide us with even greater opportunities to enrich our understanding of the current landscape of the pharmaceutical and health care sectors. Moreover, we are thrilled to have the opportunities at the conference to market our flagship products, Rutin series product and Diosmin, and to increase overall customer awareness."

About Huifeng Bio-Pharmaceutical Technology, Inc.Huifeng Bio-Pharmaceutical Technology, Inc. is a Xi'an, China-based Company engaged in the production and supply of high quality plant extracts and raw materials used to produce pharmaceuticals, nutraceuticals and food. Founded in 2000, Huifeng is the leading Chinese producer and exporter of Rutin and Rutin-related plant derived flavonoids, as well as a significant producer of Diosmin. The Company's subsidiary Shaanxi Huifeng Pharmaceutical Ltd. obtained COS Certificate in May, 2011. The Certificate number is R0-CEP 2009-032-Rev 00. Shaanxi Huifeng Pharmaceutical Ltd. is a GMP manufacturer for Rutin and Troxerutin and passed ISO9001:2000 in 2002. Both of these flavonoids are known to have antioxidant and medicinal properties and are used as ingredients in therapies that target venous diseases, inflammation, and dermatitis among other health issues. The Company is currently diversifying its product lines through internal development, acquisition and cooperation with scientific research organizations. For more information about Huifeng Bio-Pharmaceutical Technology, please visit its corporate website at: http://www.hfgb.cn

Safe Harbor StatementThis release contains certain "forward-looking statements" relating to the business of Huifeng Bio-Pharmaceutical Technology, Inc. and its subsidiary companies. These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions. Such forward-looking statements involve known and unknown risks and uncertainties that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including the risk factors set forth in the Company's annual report on Form 10-K and quarterly reports on Form 10-Q.Company Contact: Mrs. Bing HeHuifeng Bio-Pharmaceutical Technology, Inc.Tel: +86-139-919-54170Fax: +86-29-8825-0444Email: bing@xahuifeng.com
'/>"/>

SOURCE Huifeng Bio-Pharmaceutical Technology, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Huifeng Bio-Pharmaceutical Technology Announces New Senior Vice President of Finance
2. Huifeng Bio-Pharmaceutical Reported Second Quarter 2010 Financial Results and Reaffirms its 2010 Guidance
3. Huifeng Bio-Pharmaceutical Technology Announces a New Spain Order
4. Huifeng Bio-Pharmaceutical Technology Reports 26% Quarterly Revenue Increase
5. HUYA BIOSCIENCE INTERNATIONAL ENGAGES IN PARTNERSHIP WITH LIAONING (BENXI) BIO-PHARMACEUTICAL INDUSTRY BASE
6. Renhuang to Launch New Bio-pharmaceutical Product - Ginseng and Deer Antler Extract
7. Continuous Glucose Monitors: Evolving Technology, Emerging Opportunities
8. FDA Seeks Comment on Streamlined Review of Lower Risk, New Technology, Devices
9. Terumo Corporation, A Global Leader In Medical Device Technology, Celebrates 90th Anniversary
10. Antibody-Drug Conjugates 2011 - real breakthrough still to come. A Technology, Stakeholder and R&D Pipeline Analysis
11. Molecular Devices Releases Breakthrough TUNE Technology, Now Part of the SpectraMax® Paradigm® Multi-Mode Microplate Detection Platform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)...   Seno Medical Instruments, Inc. , the leader ... the development of an opto-acoustic (OA/US) imaging device, today ... SVP of Engineering. Mr. Miller previously served as the ... headquarters in Bothell, Washington . Mr. ... to the development of innovative medical imaging products that ...
(Date:1/18/2017)... 2017  Tarix Orphan LLC today announced that the ... Pediatric Disease (RPD) designation for the company,s drug candidate ... (RDEB), a rare genetic skin disorder. There are currently ... to supportive care. "The RPD designation for ... granted by the FDA in this indication," said ...
(Date:1/18/2017)... YORK , January 18, 2017 ... of people regarding the use of cannabis both for medical ... only are more Americans open to the use of cannabis, ... financial sectors. According to Arcview Market Research, the North American ... up 30% from the previous year. The research projects sales ...
Breaking Medicine Technology:
(Date:1/18/2017)... ... January 18, 2017 , ... At Hallmark Nameplate, their ... that they have achieved certification to ISO 13485. This certification is another way they ... to date products and services that they need. , The ISO 13485 Certification is ...
(Date:1/18/2017)... ... January 18, 2017 , ... The Hear the ... project with the donation of cochlear implants. In February 2017, the first three ... a fair chance of leading an independent life. This engagement builds on the ...
(Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... January is National Stalking Awareness Month ... choose to lurk in the corners and commit the crime of stalking, a very real ... and addiction, an often overlooked factor in stalking and other crimes. , “Stalking: know it. ...
(Date:1/17/2017)... ... , ... For breast cancer clinicians and researchers who were unable to attend ... intimate review and analysis of its highlights, a novel half-day, complimentary meeting—the 14th Annual ... on February 4, 2017 in Chicago. Chaired by Kathy S. Albain, MD, FACP, FASCO ...
(Date:1/17/2017)... ... January 17, 2017 , ... Kevin Harrington (one of the original Sharks from ... campaigns regarding the topic of Beauty and Personal Care. , Everyone ... better way to commit to these changes than beginning with personal care and beauty ...
Breaking Medicine News(10 mins):